Study for the Evaluation of a Non-invasive Hemodynamic Measurement in Heart Failure Patients
Trial ID or NCT#
NCT05441696
Status
RECRUITING
Purpose
Track changes in non-invasive central venous pressure across hospital stay and relationship with readmission
Official Title
Pilot Study for the Evaluation of ezCVP in Heart Failure Patients
Eligibility Criteria
Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
- - Arm circumference of 23 cm to 55 cm - Subject admitted to the hospital with acute exacerbation of heart failure, with either reduced or preserved ejection fraction - Subject is at risk for readmission (NYHA Functional Classification 2-3) - Subject is able to understand the risks and potential benefits of participating in the study and is willing to provide written, informed consent - ezCVP indicator is high (CVPNI is over 9 mmHg) at admission - Subject is willing and able to comply with protocol procedures - Subject tested negative for COVID test after admission to the hospital
Exclusion Criteria:
- - Finger and upper arm anatomical anomaly or disease that may interfere with attaching a pulse oximeter sensor and/or blood pressure cuff - Pregnant (self-reported) - Upper extremity DVT (currently being treated) - Severe skin disease involving the upper arm(s) - Study investigator may exclude patients based on clinical judgement
Investigator(s)
Masataka Kawana
Cardiologist,
Heart failure cardiologist
Assistant Professor of Medicine (Cardiovascular Medicine)
View on ClinicalTrials.gov
